Changes to Preferred Biosimilar Medications Effective October 1, 2026
Changes to Preferred Biosimilar Medications Effective October 1, 2026
Beginning October 1, 2026, MO HealthNet will change the preferred product for several biologic agents. These updates support access to high-quality, clinically effective treatments and help manage program costs responsibly. The affected biologic agents are listed below. Changes from current management appear in bold and italics.
